Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2013 December;54(6) > The Journal of Cardiovascular Surgery 2013 December;54(6):713-8

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632


eTOC

 

REVIEWS  CRITICAL LIMB ISCHEMIA AND DIABETIC FOOT: AN UPDATE


The Journal of Cardiovascular Surgery 2013 December;54(6):713-8

Copyright © 2013 EDIZIONI MINERVA MEDICA

lingua: Inglese

New devices for a better endovascular approach

Bosiers M. 1, Deloose K. 1, Callaert J. 1, Maene L. 2, Beelen R. 2, Keirse K. 3, Verbist J. 4, Peeters P. 4

1 Department of Vascular Surgery AZ Sint‑Blasius, Dendermonde, Belgium;
2 Department of Cardiovascular and Thoracic Surgery OLV Hospital, Aalst, Belgium;
3 Department of Vascular Surgery RZ Heilig Hart, Tienen, Belgium;
4 Department of Cardiovascular and Thoracic Surgery Imelda Hospital, Bonheiden, Belgium


PDF  


The endovascular approach has known a great evolution in terms of vessel patency and treatment possibilities. Longer and more complex lesions with a difficult anatomy can be addressed by a range of endovascular tools. However, to maintain the patency of the treated lesion is the true challenge. In order to fulfill these long-term expectations, newer devices have been developed. The drug-coated balloon combines local drug uptake with no residual material after treatment. To maintain patency and prevent recoil of the arterial wall, the drug-eluting stent has been created to offer stent support with an antiproliferative drug. The main drawbacks of the drug-coated balloon and the drug-eluting stent are being addressed by the drug-eluting absorbable scaffold. The initial scaffolding support in combination with the drug release during a prolonged period, poses the same advantages while the scaffold is being metabolized over time. This continuing evolution in endovascular tools paves the way to an endovascular treatment for the majority of peripheral artery diseases.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

office@fmrp.be